Nikolina Lauc is the CEO and Co-founder of GlycanAge, a leading
startup in the health-tech and longevity space whose technology was
developed over 20 years of research supported by 40 million in
European grant funding. Utilizing the largest proprietary dataset of
human glycome, GlycanAge is pioneering advanced blood biomarkers for
the prediction of age-related diseases. Recently raising a 4.2 $
million seed round, the company is endorsed by Hub71, Mubadala’s
accelerator program. Nikolina is a serial entrepreneur with proven
experience in scaling startups and leading growing teams. A Draper
University alumna and Foresight Institute fellow, last year Nikolina
was also recognized as the Entrepreneur of the Year 2023 in Croatia.